Webinar
Strawberry Creek Ventures Apex Webinar
Join Alumni Ventures’ Managing Partner Matt Caspari for a special Apex Webinar hosted by Strawberry Creek Ventures.
This session is designed to provide an in-depth look at how Strawberry Creek is sourcing, evaluating, and investing in some of the most promising startups across sectors. Matt will share recent fund updates, highlight exciting companies in the portfolio, and discuss how the team is navigating the current venture landscape.
Attendees will get a closer look at the fund’s investment strategy and learn how it aligns with broader market trends and long-term growth opportunities. Whether you’re already an investor or exploring your first venture investment, this session offers valuable insights from one of AV’s most active funds. Reserve your spot today to hear how Strawberry Creek Ventures is building a high-conviction portfolio for the Berkeley community.
Why Attend?
- HomeLearn how Strawberry Creek Ventures identifies and backs high-potential startups
- HomeGet updates on recent deals and fund performance
- HomeHear directly from Matt Caspari about investment themes shaping the fund
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Matt Caspari is a Managing Partner at Alumni Ventures, where he leads the Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds. He invests in mission-driven founders developing groundbreaking technologies. His investments encompass a diverse range of sectors, including AI, agriculture, aviation, battery technology, cybersecurity, direct air capture of CO2, energy generation, longevity, and robotics. Prior to Alumni Ventures, Matt gained operational experience as a two-time venture-backed founder/CEO and as a leader of the innovation team at Nike. He was the founding CEO of Aurora Biofuels, a deep tech venture that grew to 100+ employees, secured over $100 million in funding and was acquired by Reliance Industries. In earlier roles, Matt served as a strategic management consultant at Cambridge Pharma Consultancy, later acquired by IMS Health, and gained experience on the M&A team at Bloomberg. He holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.